The First Epidemic and New-emerging Human Fascioliasis in Kermanshah (Western Iran) and a Ten-year Follow Up, 1998-2008
نویسندگان
چکیده
BACKGROUND Fascioliasis is one of the most common zoonotic diseases in Iran and other parts of the world. Although the largest epidemic of this disease has occurred in northern provinces of Iran (Guilan) during the past two decades and a few cases have also been reported in Tehran and the other provinces, there has been no evidence of its' occurrence in western provinces of Iran such as Kermanshah before the outbreak which is being reported. METHODS The study was conducted by teamwork of infectious disease specialist, parasitologist, general practitioner, entomologist, and laboratory technician. It is an "epidemic investigation" and a cross sectional descriptive one. Clinical data and para-clinical changes are recorded considering all of the population of a village in Kangavar, one of the suburbs of Kermanshah (western Iran). RESULTS The mean age was 21.65, (SD=12.44). Fifty three percent were female, and all of them were farmers. Eighty two percent had a history of watercress ingestion in a period of 1-2 months before the admission and 18% consumed other vegetables. The average of eosinophils was 32.35% (SD=26). The patients' Enzyme Linked Immunosorbent Assay (ELISA) and Counter Current Immuno-electrophoresis (CCIE) serological tests were reported positive by the department of parasitology, Pasteur Institute of Iran. Treatment response to triclabendazole was excellent. A ten-year clinical and laboratory follow-up revealed no evidence of abnormality in treated patients. CONCLUSIONS It was the first case of human fascioliasis in west Iran and was a real epidemic and an emerging infectious disease for this area at that time. The clinical symptoms were less severe compared with other reports. Health education to inhabitants and health care workers can lead to rapid detection of such outbreaks.
منابع مشابه
CLINICAL TRIAL OF TRICLABENDAZOLE ON HUMAN FASCIOLIASIS: LONG TERM FOLLOW UP
Following an outbreak: of human fascioliasis in Gilan province of Iran in 1989, the benzimidazole derivative triclabendazole (TCBZ) was suggested as the drug of choice after finding out that routine drugs were not effective. Two studies were performed: a clinical trial (before/after type) in 1989 and a historical cohort (1989- 1995) to examine the efficacy of the drug. TCBZ was administere...
متن کاملEpidemiology of Human Fascioliasis in Iran
Fascioliasis has medical and veterinary importance in Iran. Human Fascioliasis had been limited to just ectopic cases or sporadic reports before 1988. In this year an outbreak of human fascioliasis was reported from Gilan province and peak of this epidemy was seen in spring 1989. Considering 100000 population of Bandar-e-Anzali total infected cases was estimated between 9800 and up to 20000 ...
متن کاملSUBCU TANEOUS FASCIOLIASIS: A RARE COMPLICATION
A case of ectopic fascioliasis due to migration of an immature Fasciola hepatica fluke is described in a 23 year old woman from western Iran.
متن کاملEvaluating the efficacy and side effects fingolimod in 3 -year follow-up of patients in RRMS
Fingolimod is the first DMT drug to treat MS that oral form was available. This study was done with aim to study the effectiveness and long-term side effects of bio similar fingolimod oral forms in 3-year follow-up of patients with RRMS. Methods: This study was a clinical trial (before and after) on 28 patients with RRMS referring to Clinic of Imam Reza Hospital in Kermanshah. Patients r...
متن کاملDescriptive study of Fascioliasis in Mazandaran province from seasonal
Introduction: About 2.400.000 human cases in 61 countries and 180000000 people at Fascioliasis infection risk, show the importance of human aspects of Fascioliasis around the world. In the north of our country (Iran) huge outbreaks of Fascioliasis have been seen and up to 10000 people have been infected with Fascioliasis in one of these outbreaks. So this study tries to show better criteria a...
متن کامل